Viewing Study NCT03386851


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-29 @ 9:06 PM
Study NCT ID: NCT03386851
Status: COMPLETED
Last Update Posted: 2022-02-14
First Post: 2017-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module